Carlson Investments SE

Carlson Investments SE is pleased to highlight the progress of its portfolio company Bioaccure, which has developed a compact, next-generation molecular diagnostics platform that enables real-time PCR testing directly at the point of sample collection.

Carlson Investments SE is pleased to highlight its portfolio company PUMaA TECH, a technology startup innovating in healthcare through AI and machine learning (ML).

Carlson Investments SE is pleased to highlight its portfolio company Sensus Mind, an innovator at the intersection of artificial intelligence and psychological research.

Carlson Investments SE announces that its fashion-tech portfolio company, Invis Wearables, is introducing discreet smart technology into luxury watch straps, redefining how traditional timepieces function in the connected world.

Carlson Investments SE is pleased to highlight the participation of its portfolio company, Bpower2, in a European Union co-financed initiative supporting the Mazovian ICT Cluster's efforts in digital transformation and internationalization.

Carlson Investments SE reports that its portfolio company, Debster.ai, continues to demonstrate innovation in its artificial intelligence platform for receivables management, aiming to improve efficiency and accuracy in debt collection.

Carlson Investments SE announces that its healthtech portfolio company, Nutrix AG, is progressing toward the launch of cortiSense, a non-invasive, lab-grade cortisol monitoring sensor.